These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26735910)

  • 41. Design, synthesis and evaluation of novel 7-aminoalkyl-substituted flavonoid derivatives with improved cholinesterase inhibitory activities.
    Luo W; Chen Y; Wang T; Hong C; Chang LP; Chang CC; Yang YC; Xie SQ; Wang CJ
    Bioorg Med Chem; 2016 Feb; 24(4):672-80. PubMed ID: 26752094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design, synthesis, and evaluation of 7H-thiazolo-[3,2-b]-1,2,4-triazin-7-one derivatives as dual binding site acetylcholinesterase inhibitors.
    Liu S; Shang R; Shi L; Zhou R; He J; Wan DC
    Chem Biol Drug Des; 2014 Aug; 84(2):169-74. PubMed ID: 24890706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Galantamine derivatives with indole moiety: Docking, design, synthesis and acetylcholinesterase inhibitory activity.
    Atanasova M; Stavrakov G; Philipova I; Zheleva D; Yordanov N; Doytchinova I
    Bioorg Med Chem; 2015 Sep; 23(17):5382-9. PubMed ID: 26260334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phenoxyethyl Piperidine/Morpholine Derivatives as PAS and CAS Inhibitors of Cholinesterases: Insights for Future Drug Design.
    Pourshojaei Y; Abiri A; Eskandari K; Haghighijoo Z; Edraki N; Asadipour A
    Sci Rep; 2019 Dec; 9(1):19855. PubMed ID: 31882733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phthalimide-Derived N-Benzylpyridinium Halides Targeting Cholinesterases: Synthesis and Bioactivity of New Potential Anti-Alzheimer's Disease Agents.
    Saeedi M; Golipoor M; Mahdavi M; Moradi A; Nadri H; Emami S; Foroumadi A; Shafiee A
    Arch Pharm (Weinheim); 2016 Apr; 349(4):293-301. PubMed ID: 26898241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design, synthesis and evaluation of novel 2-(aminoalkyl)-isoindoline-1,3-dione derivatives as dual-binding site acetylcholinesterase inhibitors.
    Ignasik M; Bajda M; Guzior N; Prinz M; Holzgrabe U; Malawska B
    Arch Pharm (Weinheim); 2012 Jul; 345(7):509-16. PubMed ID: 22467516
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease.
    Sharma P; Tripathi A; Tripathi PN; Prajapati SK; Seth A; Tripathi MK; Srivastava P; Tiwari V; Krishnamurthy S; Shrivastava SK
    Eur J Med Chem; 2019 Apr; 167():510-524. PubMed ID: 30784883
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, synthesis, biological evaluation and docking study of 4-isochromanone hybrids bearing N-benzyl pyridinium moiety as dual binding site acetylcholinesterase inhibitors.
    Wang C; Wu Z; Cai H; Xu S; Liu J; Jiang J; Yao H; Wu X; Xu J
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5212-6. PubMed ID: 26454504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.
    Bolognesi ML; Bartolini M; Cavalli A; Andrisano V; Rosini M; Minarini A; Melchiorre C
    J Med Chem; 2004 Nov; 47(24):5945-52. PubMed ID: 15537349
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease.
    Tasso B; Catto M; Nicolotti O; Novelli F; Tonelli M; Giangreco I; Pisani L; Sparatore A; Boido V; Carotti A; Sparatore F
    Eur J Med Chem; 2011 Jun; 46(6):2170-84. PubMed ID: 21459491
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pyridonepezils, new dual AChE inhibitors as potential drugs for the treatment of Alzheimer's disease: synthesis, biological assessment, and molecular modeling.
    Samadi A; Estrada M; Pérez C; Rodríguez-Franco MI; Iriepa I; Moraleda I; Chioua M; Marco-Contelles J
    Eur J Med Chem; 2012 Nov; 57():296-301. PubMed ID: 23078965
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and evaluation of heterobivalent tacrine derivatives as potential multi-functional anti-Alzheimer agents.
    Luo W; Li YP; He Y; Huang SL; Li D; Gu LQ; Huang ZS
    Eur J Med Chem; 2011 Jun; 46(6):2609-16. PubMed ID: 21497959
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potential of aryl-urea-benzofuranylthiazoles hybrids as multitasking agents in Alzheimer's disease.
    Kurt BZ; Gazioglu I; Basile L; Sonmez F; Ginex T; Kucukislamoglu M; Guccione S
    Eur J Med Chem; 2015 Sep; 102():80-92. PubMed ID: 26244990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis, Molecular Modeling, and Evaluation of Novel Sulfonylhydrazones as Acetylcholinesterase Inhibitors for Alzheimer's Disease.
    Fernandes TB; Cunha MR; Sakata RP; Candido TM; Baby AR; Tavares MT; Barbosa EG; Almeida WP; Parise-Filho R
    Arch Pharm (Weinheim); 2017 Nov; 350(11):. PubMed ID: 28940630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease.
    Keri RS; Quintanova C; Marques SM; Esteves AR; Cardoso SM; Santos MA
    Bioorg Med Chem; 2013 Aug; 21(15):4559-69. PubMed ID: 23768661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Indolinone-based acetylcholinesterase inhibitors: synthesis, biological activity and molecular modeling.
    Akrami H; Mirjalili BF; Khoobi M; Nadri H; Moradi A; Sakhteman A; Emami S; Foroumadi A; Shafiee A
    Eur J Med Chem; 2014 Sep; 84():375-81. PubMed ID: 25036795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of Acetylcholinesterase (AChE): A Potential Therapeutic Target to Treat Alzheimer's Disease.
    Li Y; Zhang XX; Jiang LJ; Yuan L; Cao TT; Li X; Dong L; Li Y; Yin SF
    Chem Biol Drug Des; 2015 Oct; 86(4):776-82. PubMed ID: 25736722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiple Ligands Targeting Cholinesterases and β-Amyloid: Synthesis, Biological Evaluation of Heterodimeric Compounds with Benzylamine Pharmacophore.
    Szałaj N; Bajda M; Dudek K; Brus B; Gobec S; Malawska B
    Arch Pharm (Weinheim); 2015 Aug; 348(8):556-63. PubMed ID: 26032855
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis, cytotoxicity and molecular modelling studies of new phenylcinnamide derivatives as potent inhibitors of cholinesterases.
    Saeed A; Mahesar PA; Zaib S; Khan MS; Matin A; Shahid M; Iqbal J
    Eur J Med Chem; 2014 May; 78():43-53. PubMed ID: 24675179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.